Receptor, Cannabinoid, CB1
"Receptor, Cannabinoid, CB1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of cannabinoid receptor found primarily on central and peripheral NEURONS where it may play a role modulating NEUROTRANSMITTER release.
| Descriptor ID |
D043884
|
| MeSH Number(s) |
D12.776.543.750.695.125.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptor, Cannabinoid, CB1".
Below are MeSH descriptors whose meaning is more specific than "Receptor, Cannabinoid, CB1".
This graph shows the total number of publications written about "Receptor, Cannabinoid, CB1" by people in this website by year, and whether "Receptor, Cannabinoid, CB1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptor, Cannabinoid, CB1" by people in Profiles.
-
Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. Eur J Pharmacol. 2019 Jan 15; 843:251-259.
-
Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders. Biochem Pharmacol. 2018 11; 157:258-265.
-
A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells. Bioconjug Chem. 2018 02 21; 29(2):382-389.
-
The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum. Eur J Neurosci. 2018 03; 47(6):701-708.
-
Cannabinoid CB1 receptor inverse agonist MJ08 stimulates glucose production via hepatic sympathetic innervation in rats. Eur J Pharmacol. 2017 Nov 05; 814:232-239.
-
Activation of Endocannabinoid Receptor 2 as a Mechanism of Propofol Pretreatment-Induced Cardioprotection against Ischemia-Reperfusion Injury in Rats. Oxid Med Cell Longev. 2017; 2017:2186383.
-
Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss. BMC Endocr Disord. 2017 Jul 14; 17(1):41.
-
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism. Sci Rep. 2017 02 13; 7:42157.
-
Enhancement of apamin-sensitive medium afterhyperpolarization current by anandamide and its role in excitability control in cultured hippocampal neurons. Neuropharmacology. 2011 May; 60(6):901-9.